Cours Peloton Therapeutics, Inc.
Actions
PLTX
US70614L1044
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01/11/17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01/01/11 |
David Chang
BRD | Director/Board Member | 64 | 01/02/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
-3,46% | 102 Md | |
+1,41% | 96,29 Md | |
+2,13% | 22,18 Md | |
-15,84% | 21,2 Md | |
-9,21% | 18,31 Md | |
-39,98% | 17,38 Md | |
-14,65% | 16,36 Md | |
+4,39% | 13,97 Md | |
+31,35% | 12,17 Md |